230 related articles for article (PubMed ID: 14736722)
1. Clindamycin in the treatment of Babesia gibsoni infections in dogs.
Wulansari R; Wijaya A; Ano H; Horii Y; Nasu T; Yamane S; Makimura S
J Am Anim Hosp Assoc; 2003; 39(6):558-62. PubMed ID: 14736722
[TBL] [Abstract][Full Text] [Related]
2. Efficacy of atovaquone against Babesia gibsoni in vivo and in vitro.
Matsuu A; Koshida Y; Kawahara M; Inoue K; Ikadai H; Hikasa Y; Okano S; Higuchi S
Vet Parasitol; 2004 Sep; 124(1-2):9-18. PubMed ID: 15350657
[TBL] [Abstract][Full Text] [Related]
3. Development and characterization of a strain of Babesia gibsoni resistant to diminazene aceturate in vitro.
Hwang SJ; Yamasaki M; Nakamura K; Sasaki N; Murakami M; Wickramasekara Rajapakshage BK; Ohta H; Maede Y; Takiguchi M
J Vet Med Sci; 2010 Jun; 72(6):765-71. PubMed ID: 20160418
[TBL] [Abstract][Full Text] [Related]
4. Short report: cloning of the Babesia gibsoni cytochrome B gene and isolation of three single nucleotide polymorphisms from parasites present after atovaquone treatment.
Matsuu A; Miyamoto K; Ikadai H; Okano S; Higuchi S
Am J Trop Med Hyg; 2006 Apr; 74(4):593-7. PubMed ID: 16606990
[TBL] [Abstract][Full Text] [Related]
5. Antiprotozoal treatment of canine babesiosis.
Baneth G
Vet Parasitol; 2018 Apr; 254():58-63. PubMed ID: 29657012
[TBL] [Abstract][Full Text] [Related]
6. Lymphocyte subsets and specific IgG antibody levels in clindamycin-treated and untreated dogs experimentally infected with Babesia gibsoni.
Wulansari R; Wijaya A; Ano H; Horii Y; Makimura S
J Vet Med Sci; 2003 May; 65(5):579-84. PubMed ID: 12808209
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of Azithromycin and Compounded Atovaquone for Treatment of Babesia gibsoni in Dogs.
Kirk SK; Levy JK; Crawford PC
J Vet Intern Med; 2017 Jul; 31(4):1108-1112. PubMed ID: 28625019
[TBL] [Abstract][Full Text] [Related]
8. The in vitro interactions and in vivo efficacy of atovaquone and proguanil against Babesia gibsoni infection in dogs.
Iguchi A; Matsuu A; Fujii Y; Ikadai H; Hikasa Y
Vet Parasitol; 2013 Nov; 197(3-4):527-33. PubMed ID: 24075418
[TBL] [Abstract][Full Text] [Related]
9. A Possible treatment strategy and clinical factors to estimate the treatment response in Bebesia gibsoni infection.
Suzuki K; Wakabayashi H; Takahashi M; Fukushima K; Yabuki A; Endo Y
J Vet Med Sci; 2007 May; 69(5):563-8. PubMed ID: 17551236
[TBL] [Abstract][Full Text] [Related]
10. Possible emergence of drug-resistant variants of Babesia gibsoni in clinical cases treated with atovaquone and azithromycin.
Sakuma M; Setoguchi A; Endo Y
J Vet Intern Med; 2009; 23(3):493-8. PubMed ID: 19645835
[TBL] [Abstract][Full Text] [Related]
11. In vitro and in vivo safety and efficacy studies of amphotericin B on Babesia gibsoni.
Yamasaki M; Harada E; Tamura Y; Lim SY; Ohsuga T; Yokoyama N; Morishita K; Nakamura K; Ohta H; Takiguchi M
Vet Parasitol; 2014 Oct; 205(3-4):424-33. PubMed ID: 25260334
[TBL] [Abstract][Full Text] [Related]
12. Frequency and therapy monitoring of canine Babesia spp. infection by high-resolution melting curve quantitative FRET-PCR.
Wang C; Ahluwalia SK; Li Y; Gao D; Poudel A; Chowdhury E; Boudreaux MK; Kaltenboeck B
Vet Parasitol; 2010 Feb; 168(1-2):11-8. PubMed ID: 19931290
[TBL] [Abstract][Full Text] [Related]
13. The therapeutic efficacy of two antibabesial strategies against Babesia gibsoni.
Lin EC; Chueh LL; Lin CN; Hsieh LE; Su BL
Vet Parasitol; 2012 May; 186(3-4):159-64. PubMed ID: 22222008
[TBL] [Abstract][Full Text] [Related]
14. [On the chemotherapy of Babesia gibsoni infection in dogs].
Bauer F
Zentralbl Veterinarmed B; 1967 Mar; 14(2):170-8. PubMed ID: 5594732
[No Abstract] [Full Text] [Related]
15. Morphological changes of Babesia gibsoni grown in canine red blood cell-substituted severe combined immune deficiency mice.
Fukumoto S; Xuan X; Igarashi I; Zhang S; Mugisha J; Ogata T; Nagasawa H; Fujisaki K; Suzuki N; Mikami T
J Parasitol; 2000 Oct; 86(5):956-8. PubMed ID: 11128518
[TBL] [Abstract][Full Text] [Related]
16. Transfusion-associated Babesia gibsoni infection in a dog.
Stegeman JR; Birkenheuer AJ; Kruger JM; Breitschwerdt EB
J Am Vet Med Assoc; 2003 Apr; 222(7):959-63, 952. PubMed ID: 12685786
[TBL] [Abstract][Full Text] [Related]
17. Re-emergence of Babesia conradae and effective treatment of infected dogs with atovaquone and azithromycin.
Di Cicco MF; Downey ME; Beeler E; Marr H; Cyrog P; Kidd L; Diniz PP; Cohn LA; Birkenheuer AJ
Vet Parasitol; 2012 Jun; 187(1-2):23-7. PubMed ID: 22305297
[TBL] [Abstract][Full Text] [Related]
18. Use of a doxycycline-enrofloxacin-metronidazole combination with/without diminazene diaceturate to treat naturally occurring canine babesiosis caused by Babesia gibsoni.
Lin MY; Huang HP
Acta Vet Scand; 2010 Apr; 52(1):27. PubMed ID: 20416095
[TBL] [Abstract][Full Text] [Related]
19. Chemotherapy against babesiosis.
Vial HJ; Gorenflot A
Vet Parasitol; 2006 May; 138(1-2):147-60. PubMed ID: 16504402
[TBL] [Abstract][Full Text] [Related]
20. Babesia gibsoni: detection during experimental infections and after combined atovaquone and azithromycin therapy.
Jefferies R; Ryan UM; Jardine J; Robertson ID; Irwin PJ
Exp Parasitol; 2007 Oct; 117(2):115-23. PubMed ID: 17543304
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
